학술논문

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Document Type
article
Author
Johnson, NicholaMaguire, SarahMorra, AnnaKapoor, Pooja MiddhaTomczyk, KatarzynaJones, Michael ESchoemaker, Minouk JGilham, ClareBolla, Manjeet KWang, QinDennis, JoeAhearn, Thomas UAndrulis, Irene LAnton-Culver, HodaAntonenkova, Natalia NArndt, VolkerAronson, Kristan JAugustinsson, AnnelieBaynes, CarolineFreeman, Laura E BeaneBeckmann, Matthias WBenitez, JavierBermisheva, MarinaBlomqvist, CarlBoeckx, BramBogdanova, Natalia VBojesen, Stig EBrauch, HiltrudBrenner, HermannBurwinkel, BarbaraCampa, DanieleCanzian, FedericoCastelao, Jose EChanock, Stephen JChenevix-Trench, GeorgiaClarke, Christine LConroy, Don MCouch, Fergus JCox, AngelaCross, Simon SCzene, KamilaDörk, ThiloEliassen, A HeatherEngel, ChristophEvans, D GarethFasching, Peter AFigueroa, JonineFloris, GiuseppeFlyger, HenrikGago-Dominguez, ManuelaGapstur, Susan MGarcía-Closas, MontserratGaudet, Mia MGiles, Graham GGoldberg, Mark SGonzález-Neira, AnnaGuénel, PascalHahnen, EricHaiman, Christopher AHåkansson, NiclasHall, PerHamann, UteHarrington, Patricia AHart, Steven NHooning, Maartje JHopper, John LHowell, AnthonyHunter, David JJager, AgnesJakubowska, AnnaJohn, Esther MKaaks, RudolfKeeman, RenskeKhusnutdinova, ElzaKitahara, Cari MKosma, Veli-MattiKoutros, StellaKraft, PeterKristensen, Vessela NKurian, Allison WLambrechts, DietherLe Marchand, LoicLinet, MarthaLubiński, JanMannermaa, ArtoManoukian, SiranoushMargolin, SaraMartens, John WMMavroudis, DimitriosMayes, RebeccaMeindl, AlfonsMilne, Roger LNeuhausen, Susan LNevanlinna, HeliNewman, William GNielsen, Sune FNordestgaard, Børge GObi, NadiaOlshan, Andrew FOlson, Janet E
Source
British Journal of Cancer. 124(4)
Subject
Estrogen
Human Genome
Clinical Research
Cancer
Aging
Breast Cancer
Genetics
2.1 Biological and endogenous factors
Aetiology
Alleles
Breast Neoplasms
Case-Control Studies
Cytochrome P-450 CYP3A
Estrone
Female
Genome-Wide Association Study
Humans
Polymorphism
Single Nucleotide
Pregnanediol
Premenopause
Progesterone
Receptors
Estrogen
Receptors
Progesterone
NBCS Collaborators
AOCS Group
ABCTB Investigators
kConFab Investigators
Oncology and Carcinogenesis
Public Health and Health Services
Oncology & Carcinogenesis
Language
Abstract
BackgroundEpidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk.MethodsWe carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry.ResultsFor pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (-49.2%, 95% CI -56.1% to -41.1%, P = 3.1 × 10-18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (-26.7%, 95% CI -39.4% to -11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82-0.91, P = 6.9 × 10-8).ConclusionsThe CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.